Variations in the amount of zinc in human blood cells have been correlated with several diseases and morphological features. In 1949, Vallee and Gibson observed that in pernicious anemia erythrocyte zinc is elevated to a degree even exceeding what might be related to macrocytosis (1) . A correlation of carbonic anhydrase activity with erythrocyte zinc content was demonstrated (2, 3) . Subsequent reports concerning erythrocyte zinc have shown that it is decreased in the fetus and newborn (3) and is increased in some patients with chronic leukemias and sickle-cell anemia (1, 2, (4) (5) (6) (7) (8) . The first evidence concerning leukocyte zinc abnormalities was reported in 1949 by Vallee, Gibson, Fluharty, and Nelson (1, 4) , who noted markedly decreased zinc in leukocytes from patients with chronic leukemias. They also described a rise in leukocyte zinc towards normal when subjects with chronic granulocytic leukemia responded to therapy. We have reported on the decreased amount of zinc in leukocytes of patients with hepatic cirrhosis (9) , and high zinc levels in eosinophils have been described (10, 11) .
This study was undertaken to evaluate the levels of erythrocyte and leukocyte zinc in a large group of patients with a variety of hematological and nonhematological diseases and to examine these cellular zinc levels in relationship to peripheral blood cell morphology, blood counts, leukocyte alkaline phosphatase activity, disease state, and treatment status. Included in the study are patients with acute and chronic leukemias, polycythemia rubra vera, myeloid metaplasia, megaloblastic and other anemias, eosinophilia owing to various causes, and pneumonia, and patients in the postpartum state. 
Methods
The methods of obtaining cells, preparing erythrocyte-and leukocyte-rich suspensions, and measuring the acid-extracted zinc in a dithizone and carbon tetrachloride solution have been previously described (9, 12) . In most cases duplicate determinations were made on each sample, and the duplicate values were averaged, so that a single result, corrected for erythrocyte or leukocyte contamination, was recorded for each sample studied.
Leukocyte alkaline phosphatase was determined according to the method of Valentine and Beck (13) . Standard methods were used to measure the hematological parameters, except that total blood cell counts were done with a Coulter counter and randomly checked by visual counts in hemocytometers.
The usual clinical and laboratory criteria were used in establishing diagnoses, and each case was reviewed by at least two of us, so that equivocal cases would be excluded. In this report the term (Tables II and III) . Correlation coefficients in-lynmphocytic leukemia r is plus 0.101. The indedicate the lack of correlation between total leuko-pendence of leukocyte zinc values and the difcyte counts and leukocyte zinc; in chronic granu-ferential leukocyte counts is further emphasized 
e,00 t-.~4 U) ' Values in patients with chronic lymphocytic leukemia. There is no significant difference between the leukocyte zinc levels of the treated and untreated groups with chronic lymphocytic leukemia. Although there is no definite correlation of leukocyte zinc with the total leukocyte counts in this group, it may be significant that no zinc was recovered from the leukocytes of the patient with the highest leukocyte count (450,000 per mm3), whereas the greatest leukocyte zinc levels were found in the cases that had the lowest total leukocyte counts (Table II) .
Values in patients with chronic granulocytic leukemia. The data for the chronic granulocytic leukemia group are remarkable in that leukocyte zinc shows a rise with response to treatment, as demonstrated by the difference in mean values for leukocyte zinc between the treated and untreated cases (Table I) and also by the individual responses of patients for whom serial determinations were done (Table III Although the generalization about the lack of correlation of leukocyte zinc with total leukocyte counts applies to the group with chronic granulocytic leukemia, the highest leukocyte zinc values were found in the cases with the lowest counts, and the converse is also true. In the twelve de Table V .
Zinc values related to leukocyte alkaline phosphatase. In many of the cases of leukemia, polycythemia, and myeloid metaplasia, leukocyte alkaline phosphatase activity was measured on portions of the blood samples obtained for zinc determinations (Tables II, III , and V). The results clearly show that levels of leukocyte alkaline phosphatase and values for zinc in leukocytes are completely independent of each other.
Values in anemia, eosinophilia, pneumonia, and postpartum cases. Three patients with megaloblastic anemia (two due to folic acid deficiency and one due to pernicious anemia) were studied. Pretreatment blood samples were analyzed in each case, and in each there was a markedly elevated erythrocyte zinc value. In the two cases of folic acid-deficiency anemia in which posttreatment blood samples could be obtained, the erythrocyte zinc decreased as MCV declined and the packed cell volume and hemoglobin increased (Table VI) .
Sufficient leukocytes for zinc analysis could be obtained only from patient H.W. after his third week of folic acid therapy. The first leukocyte zinc value was significantly low, but the leukocyte zinc rose into the normal range after an additional week of treatment, when the erythrocyte zinc value had fallen to normal.
Patients with paroxysmal nocturnal hemoglobinuria had normal erythrocyte zinc in the four cases studied. Sufficient leukocytes for study could not be obtained from these patients because of the characteristic low leukocyte counts. Six patients with leukocytosis owing to pneumonia had normal blood cell zinc values, except for the one patient who also had cirrhosis. In the latter, leukocyte zinc was distinctly low, 29.2 pg of zinc per 1010 leukocytes.
Leukocyte and erythrocyte zinc values on samples from one woman during labor and from six during the immediate postpartum period were distributed in the normal range.
Discussion
Our studies (6) and those of Wolff (11) and of Dennes, Tupper, and Wormall (7, 8) have shown again that there is a decrease in the zinc content of leukocytes from persons with chronic lymphocytic and chronic granulocytic leukemias, as originally observed by Gibson and associates (4) . In addition, this report points up that a) leukocytes of patients with acute lymphocytic leukemia and myeloid metaplasia also have a low level of zinc, whereas the leukocytes in acute monocytic and acute granulocytic leukemia contain about 80 to 95% of the normal amount of zinc, b) the leukocytes in polycythemia vera and leukocytosis contain zinc in normal amounts, and c) the leukocytes in megaloblastic anemia may be zinc deficient.
Attempts have been made to correlate variations inl letnkocyte zinc levels with the differential leukocyte connts, the degree of inmmaturity of the letikocytes, the total leukocyte counts, and various modes of therapy used in the diseases studied.
NVolff (11) has reported that eosinophils contain large amounts of zinc, and the histochemical studies of Mager, McNary, and Lionetti (10) confirm this characteristic; however, the values found in this study do not show any correlation of zinc content with the eosinophil counts in a group of seven patients with eosinophilia ranging from 12.5 to 73.5%o. Extensive tables in this paper demonstrate further the great variations in differential cell counts present in cases with similar leukocyte zinc values. For example, there is a striking similarity between the zinc levels in chronic lymphocytic leukemia, where leukocyte samples contain almost pure lymphocytes, and in chronic granulocytic leukemia, where leukocyte suspensions contain variable percentages of neutrophilic forms, eosinophils, and basophils (most strikingly, 76%o basophils as shown for D.N. in Table III ).
Wolff (11), Candura and Candura (14) , and de Nicola and Candura (15) have offered evidence that the leukocyte zinc level varies with cellular maturity, being lowest in the most immature cells. Wolff based his conclusion on the evaluation of cases of chronic leukemia, and the Italian workers included just one example of acute leukemia among the seven cases of leukemia that they used in graphing this relationship. A relationship between leukocyte zinc and cellular maturity is not apparent from the data detailed in Tables II, III, and V, and the most obvious argument opposing this concept is that the leukocyte zinc levels in acute granulocytic and acute monocytic leukemias exceed those found in cases with chronic leukemia, as shown in Table I .
An inverse relationship between the total peripheral leukocyte count and leukocyte zinc content in chronic lymphocytic leukemia has been reported by Dennes and associates (8) . The data of this study do not reveal a similar clear-cut association, although leukocyte zinc values in chronic lymphocytic leukemia and also in chronic granulocytic leukemia are lowest in the cases that had the highest leukocyte counts, and greatest in the cases with the lowest total leukocyte counts. There is 311 no correlative association between total leukocyte counts of peripheral blood and leukocyte zinc values in the various other groups presented here, or in the previously reported study of patients with cirrhosis (9) ; the maximal correlation coefficients are plus 0.522 and minus 0.558.
As seen in Tables I and III, (1, 2, (4) (5) (6) (7) (8) .
The results reported here substantiate these findings and also those of Dennes and associates (8) , who observed that the range of erythrocyte zinc values is much greater in chronic leukemic subjects than in normal subjects. In addition, we have found elevated erythrocyte zinc levels in patients with acute lymphocytic leukemia, acute monocytic leukemia, and myeloid metaplasia. We have previously commented on the broad range of erythrocyte zinc levels in patients with cirrhosis (9) and on the possible correlation of these values with the MCV of the erythrocytes; a similar correlation is suggested by the data for polycythemia vera and myeloid metaplasia tabulated in Table V . No other relationship of erythrocyte zinc to hematological determinations, disease state, or treatment status has been detected.
The direct relationship of erythrocyte zinc levels to carbonic anhydrase activity of the erythrocytes was first described by Vallee, Lewis, Altschule, and Gibson in 1949 (2) . This close association has never been discounted; however, the study of Dennes, Tupper, and Wormall (19) , in which they measured radioactive zinc65 uptake by blood cells, has demonstrated that there is a portion of erythrocyte zinc which exchanges freely with the body pool of zinc and is apparently not complexed in any intimate chemical union with proteins of the cells, whereas the zinc of carbonic anhydrase is a closely held constituent of that enzyme and cannot be dialyzed out of the cell even with potent zinc chelating agents (8) .
It is not likely that easily exchanged or "labile" zinc could contribute to the increased concentration of erythrocyte zinc reported in certain diseases. In the methods used in determining our data and that of other published reports concerning increased erythrocyte zinc, the "labile" portion of zinc in erythrocytes is probably removed during the cell washings (8) that precede the analysis of the zinc content. The measured erythrocyte zinc probably represents the "stable" zinc, the protein-bound zinc, which is incorporated in the carbonic anhydrase molecule. Previously published reports have shown that serum zinc levels are reduced in the clinical situations in which we find increased erythrocyte zinc values (20) . This fact would lead one to postulate that the "labile" zinc in these erythrocytes would decrease, because of the tendency for the "labile" zinc of the cells to be equilibrated with the body zinc pool, as most immediately reflected in the erythrocyte's plasma environment.
Many of the findings discussed in this paper are graphically represented in Figure 1 , which illustrates that there is a reciprocal relationship between leukocyte and erythrocyte zinc levels. Erythrocyte zinc tends to be increased in those clinical states in which leukocyte zinc is decreased, with the notable exception of the cases of cirrhosis in which the average erythrocyte zinc value is normal even though leukocyte zinc is decreased (9) . Greatly elevated leukocyte zinc was found in only one instance, in a patient with polycythemia vera (S.B. in Table V) , and his erythrocyte zinc was reciprocally decreased. It has also been reported that serum zinc may be increased in some cases of polycythemia vera (20 The abnormal leukocyte zinc levels may reflect long-standing disturbances in serum zinc. In cirrhosis serum zinc is depleted apparently because of the associated zincuria (21) . Increased binding of zinc by erythrocytes may be responsible for reducing serum zinc in cases of megaloblastic anemia, chronic leukemia, acute lymphocytic leukemia, and myeloid metaplasia. Decreased serum zinc might be expected to be reflected first in the leukocytes, because they have a rapid turnover and also because they ordinarily take up and bind 30 to 75 times more zinc than erythrocytes. Cases of polycythemia rubra vera may provide us with a model for defining these interrelationships, since an occasional florid case has a reduction of erythrocyte zinc and an increase of serum zinc that may be responsible for the elevation of leukocyte zinc. were noted in cases of chronic leukemia and acute lymphocytic leukemia.
2) The rise of leukocyte zinc content with response to therapy in chronic granulocytic leukemia is confirmed.
3) Leukocyte zinc was normal in 16 and elevated in one determination on samples from patients with polycythemia rubra vera, but significantly decreased in six patients with myeloid metaplasia. 4) In one patient with megaloblastic anemia, leukocyte zinc rose from a low level into the normal range with response to therapy and subsidence of the anemia. 5) Leukocyte zinc was normal in six patients with leukocytosis due to pneumonia. 6) Leukocyte and erythrocyte zinc levels were normal in seven women during labor or the immediate postpartum period.
7) Leukocyte zinc levels could not be correlated with eosinophilia, basophilia, or other variations in differential leukocyte counts or with total leukocyte counts or with the degree of leukocyte immaturity.
8) The level of leukocyte alkaline phosphatase activity shows no relationship to leukocyte zinc levels.
9) Erythrocyte zinc content is often increased in patients with chronic leukemias, acute lymphocytic leukemia, acute monocytic leukemia, and myeloid metaplasia. 10) As reported by others, we found that erythrocyte zinc is increased in megaloblastic anemia and declines with response to therapy. 11) In some cases the erythrocyte zinc content seems to correlate with the mean corpuscular volume of the erythrocytes, but in most cases shows no correlation with the degree of anemia or other factors.
12) There does seem to be a reciprocal relationship between leukocyte and erythrocyte zinc levels in various disease states, and the possible implications of this observation are discussed.
